Diagnostic Yield of Extended Cardiac Patch Monitoring in Patients with Stroke or TIA

Christie E Tung, Derek Su, Mintu P Turakhia, Maarten G Lansberg, Christie E Tung, Derek Su, Mintu P Turakhia, Maarten G Lansberg

Abstract

Background: It is important to evaluate patients with transient ischemic attack (TIA) or stroke for atrial fibrillation (AF) because the detection of AF changes the recommended anti-thrombotic regimen from treatment with an antiplatelet agent to oral anticoagulation. This study describes the diagnostic yield of a patch-based, single-use, and water-resistant 14-day continuous cardiac rhythm monitor (ZIO Patch) in patients with stroke or TIA.

Methods: We obtained data from the manufacturer and servicer of the ZIO Patch (iRhythm Technologies). Patients who were monitored between January 2012 and June 2013 and whose indication for monitoring was TIA or stroke were included. The duration of monitoring, the number and type of arrhythmias, and the time to first arrhythmia were documented.

Results: One thousand one hundred seventy-one monitoring reports were analyzed. The mean monitor wear time was 10.9 days and the median wear time was 13.0 days (interquartile range 7.2-14.0). The median analyzable time relative to the total wear time was 98.7% (IQR 96.0-99.5%). AF was present in 5.0% of all reports. The mean duration before the first episode of paroxysmal AF (PAF) was 1.5 days and the median duration was 0.4 days. 14.3% of first PAF episodes occurred after 48 h. The mean PAF burden was 12.7% of the total monitoring duration.

Conclusion: Excellent quality of the recordings and very good patient compliance coupled with a substantial proportion of AF detection beyond the first 48 h of monitoring suggest that the cardiac patch is superior to conventional 48-h Holter monitors for AF detection in patients with stroke or TIA.

Keywords: SVT; TIA; arrhythmias; atrial fibrillation; cardiac; cardiac monitoring; stroke; telemetry.

Figures

Figure 1
Figure 1
Ziopatch cardiac monitor. Zio Patch button and placement. (A) Patients can press a button on the Zio Patch to mark a symptomatic episode. (B) The device is placed over the patient’s left pectoral region. (Images courtesy of iRhythm Technologies, Inc., San Francisco, CA, USA.)
Figure 2
Figure 2
Cumulative frequency of atrial fibrillation. Shown is the probability of detection of atrial fibrillation in stroke and TIA patients with cardiac patch monitoring up to 14 days. The data are shown on an enlarged y-axis.

References

    1. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 45:2160–23610.1161/STR.0000000000000024
    1. Kishore A, Vail A, Dawson J, Lees KR, Tyrrell PJ, Smith CJ. Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic meta-analysis. Stroke (2014) 45:520–6.10.1161/STROKEAHA.113.003433
    1. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med (2014) 370:2478–86.10.1056/NEJMoa1313600
    1. Ziegler PD, Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, et al. Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events. Stroke (2010) 41:256–60.10.1161/STROKEAHA.109.571455
    1. Brambatti M, Connolly SJ, Gold MR, Morillo CA, Capucci A, Muto C, et al. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation (2014) 129:2094–9.10.1161/CIRCULATIONAHA.113.007825
    1. Binici Z, Intzilakis T, Nielsen OW, Kober L, Sajadieh A. Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation (2010) 121:1904–11.10.1161/CIRCULATIONAHA.109.874982
    1. Ackermans PA, Solosko TA, Spencer EC, Gehman SE, Manni K, Engel J, et al. A user-friendly integrated monitor-adhesive patch for long-term ambulatory electrocardiogram monitoring. J Electrocardiol (2012) 45:148–53.10.1016/j.jelectrocard.2011.10.007
    1. Turakhia MP, Hoang DD, Zimetbaum P, Miller JD, Froelicher VF, Kumar UN, et al. Diagnostic utility of a novel leadless arrhythmia monitoring device. Am J Cardiol (2013) 112:520–4.10.1016/j.amjcard.2013.04.017
    1. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med (2012) 366:120–910.1056/NEJMoa1105575
    1. Rothman SA, Laughlin JC, Seltzer J, Walia JS, Baman RI, Siouffi SY, et al. The diagnosis of cardiac arrthymias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop monitoring. J Cardiovasc Electrophysiol (2007) 18:241–7.10.1111/j.1540-8167.2006.00729.x
    1. Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med (2014) 370:2467–7710.1056/NEJMoa1311376

Source: PubMed

3
Subskrybuj